Covista Inc. vs UNIVERSAL TECHNICAL INSTITUTE, INC, two Education stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVSA and UTI diverge most: on operating margin, CVSA reads 18.8% and UTI reads 0.1%; on fcf yield, CVSA reads 7.4% and UTI reads 0.1%. The rest of the comparable metrics sit closer together. What CVSA's price implies is a bet that sits within the historical range (whole-company basis). What UTI's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVSA | UTI |
|---|---|---|
| Price | $130.63 | $48.48 |
| Market cap | $4.5B | $2.7B |
| Sector | Education | Education |
| Stage | Mature | Mature |
| Implied growth (priced in) | -0.8% | — |
| P/E | 20.4 | 63.8 |
| P/B | 3.33 | 7.95 |
| P/S | 2.38 | 3.11 |
| EV/EBITDA | 12.0 | 30.6 |
| Revenue growth | +9.8% | +11.2% |
| Operating margin | 18.8% | 0.1% |
| Net margin | 12.3% | 4.9% |
| Return on equity | 17.2% | 12.6% |
| Return on assets | 8.6% | 5.0% |
| Return on invested capital | 14.5% | 9.2% |
| FCF yield | 7.4% | 0.1% |
| Debt / equity | 0.37 | 0.39 |
| Current ratio | 0.70 | 1.17 |
| Altman Z (solvency) | 4.23 | 4.42 |
| Piotroski F (quality) | 6 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.